STRUTHERS RICHARD SCOTT (See Remarks) sold 5.2% of their position (21.98K shares) of CRINETICS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $821.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/18/2026ACC: 0001628280-26-019488
DirectorOfficer· See Remarks
Since Jul 2018
-21.98K
Net shares
Net seller
$821.5K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
21.98K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−13.20K
Price / share
$37.11
Trade value
$489.70K
% of position
3.1%
3/16/2026
426.76K→413.56K
Common Stock
Direct
Shares
−8.79K
Price / share
$37.77
Trade value
$331.81K
% of position
2.1%
3/16/2026
413.56K→404.78K
Total
Net shares
−21.98K
Net value
-$821.51K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/16/2026 | S · Sale | −13.20K | $37.11 | $489.70K | 3.1% | 426.76K | 413.56K |
| Common Stock Direct | 3/16/2026 | S · Sale | −8.79K | $37.77 | $331.81K | 2.1% | 413.56K | 404.78K |
| Total | −21.98K | -$821.51K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)5
Common Stock
IndirectShares owned110K
Common Stock
IndirectShares owned661.21K
Common Stock
IndirectShares owned1K
Common Stock
IndirectShares owned106K
Common Stock
IndirectShares owned100K
Total
978.21K indirect978.21K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 110K | Indirect |
| Common Stock | 661.21K | Indirect |
| Common Stock | 1K | Indirect |
| Common Stock | 106K | Indirect |
| Common Stock | 100K | Indirect |
| Total | 978.21K | 978.21K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported